English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

© 2013 The Authors. doi: 10.2340/00015555-1419 Journal Compilation © 2013 Acta Dermato-Venereologica. ISSN 0001-5555 Tuberculosis (TB) is an infectious disease, its causative agent being Gram-negative, aerobic, acid-fast bacillus Mycobacterium tuberculosis, or, less frequently, M. bovis. Approximately 10% of patients with AIDS have TB. There are 8.8 million new cases worldwide per year, including 1.4 million fatalities, according to 2010 statistics (1). The WHO’s TB estimates for 2015 are 1 billion infections, 200 million people ill, and 35 million fatalities (1, 2). Principally, these numbers reflect case numbers in resource-poor countries, such as in sub-Saharan Africa, where the incidence rate of TB is the highest, at 363/100,000. In the highly developed countries in Europe, the incidence rate is 10.4/100,000. In Poland, in 2009 the incidence rate is 21.6/100,000 (1–3). Apart from pulmonary infections (approximately 92% of all cases), TB may cause pleural effusion, lymph node infections, urinary tract infections and infections of the bone. Tuberculosis of the skin is rare. In Poland it represents < 1% of the registered TB cases (3). CASE REPORT

Extensive Chronic Tuberculosis luposa Treated Incorrectly with Long-term Course of Isoniazid Monotherapy